Guj. Inject(Ker), a company in the Pharmaceuticals industry, reported revenue of ₹5.82 crore and net profit of ₹0.73 crore for the September 2026 quarter.
Guj. Inject(Ker) (BSE: GUJINJEC) closed at ₹10.45 on 20 Nov 2026, up 301.9% over the past year. Its market capitalisation is ₹153 crore and it trades at 41.8 times earnings.
Gujarat Inject (Kerala) Ltd has discontinued its legacy pharmaceutical manufacturing operations and currently follows a trading -led business model transitioning towards renewable energy. Its disclosed activities include supplying 600–620Wp solar-PV modules, investing in a 5MW solar project and evaluating thermal-energy-storage opportunities.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.